<p>根据公司在最近向证券交易委员会的披露，Federated Hermes Inc. 在第二季度将其在 Revvity Inc.（纽约证券交易所代码：RVTY - 免费报告）中的股份减少了 9.5%。该机构投资者在此期间出售了 22,482 股后，持有 213,182 股该公司的股票。截至其最近向证券交易委员会的备案，Federated Hermes Inc. 持有 Revvity 约 0.18% 的股份，价值 20,619,000 美元。</p>
<p>其他机构投资者和对冲基金最近也增加或减少了对该公司的持股。凯通国际资产管理有限公司在第一季度将其在 Revvity 的持股增加了 25.3%。凯通国际资产管理有限公司目前持有 694 股该公司的股票，价值 73,000 美元，此前在上个季度又购买了 140 股。跨大西洋银行在第一季度将其在 Revvity 的持股增加了 19.4%。跨大西洋银行目前持有 925 股该公司的股票，价值 90,000 美元，此前在此期间又收购了 150 股。CVA Family Office LLC 在第二季度将其在 Revvity 的持股增加了 79.0%。CVA Family Office LLC 目前持有 410 股该公司的股票，价值 40,000 美元，此前在上个季度又购买了 181 股。EverSource Wealth Advisors LLC 在第二季度将其在 Revvity 的持股增加了 25.9%。EverSource Wealth Advisors LLC 目前持有 900 股该公司的股票，价值 87,000 美元，此前在上个季度又购买了 185 股。最后，Leslie Global Wealth LLC 在第二季度将其在 Revvity 的持股增加了 9.3%。Leslie Global Wealth LLC 目前持有 2,195 股该公司的股票，价值 212,000 美元，此前在上个季度又购买了 186 股。目前 86.65% 的股票由机构投资者和对冲基金持有。</p>
<h2>分析师评级调整</h2>
<p>几家研究公司对 RVTY 发表了看法。巴克莱将 Revvity 的目标价格从 100.00 美元上调至 105.00 美元，并在 10 月 28 日的报告中给予该公司 “超配” 评级。Weiss Ratings 在周一的研究报告中重新发布了对 Revvity 股票的 “卖出（d）” 评级。美国银行在 9 月 22 日的研究报告中将 Revvity 的目标价格从 110.00 美元下调至 99.00 美元，并为该公司设定了 “买入” 评级。罗伯特·W·贝尔德在 10 月 28 日的研究报告中将 Revvity 的目标价格从 122.00 美元上调至 123.00 美元，并给予该公司 “跑赢大盘” 评级。最后，Evercore ISI 在 10 月 27 日的研究报告中重新发布了 “跑赢大盘” 评级，并为 Revvity 设定了 108.00 美元的目标价格。七位股票研究分析师对该股票给予了买入评级，六位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “持有”，平均目标价格为 113.08 美元。</p>
<p><strong>查看我们最新的 RVTY 股票分析</strong></p>
<h2>Revvity 价格表现</h2>
<p>Revvity 股票在周三开盘价为 98.85 美元。该公司的市值为 112.1 亿美元，市盈率为 49.67，市盈增长比率为 3.30，贝塔值为 1.06。Revvity Inc.的 12 个月最低价为 81.36 美元，最高价为 128.29 美元。该公司的债务与股本比率为 0.36，流动比率为 1.75，速动比率为 1.44。该公司的 50 日移动平均线为 95.54 美元，200 日移动平均线为 93.12 美元。</p>
<p>Revvity（纽约证券交易所代码：RVTY - 获取免费报告）最近在 10 月 27 日发布了季度财报。该公司报告本季度每股收益为 1.18 美元，超出分析师共识预期的 1.14 美元，超出幅度为 0.04 美元。Revvity 的净利润率为 8.44%，股本回报率为 7.52%。该公司在本季度的收入为 6.9895 亿美元，而分析师预期为 6.9975 亿美元。在去年同期，该公司每股收益为 1.28 美元。该公司的收入同比增长了 2.2%。Revvity 已将其 2025 财年的指导目标设定为 4.900-5.000 每股收益。股票分析师预测 Revvity Inc.在当前年度将发布 4.94 美元的每股收益。</p>
<h2>Revvity 股息公告</h2>
<p>该公司最近还披露了一项季度股息，将于 2 月 6 日（星期五）支付。1 月 16 日（星期五）登记的股东将获得每股 0.07 美元的股息。除息日期为 1 月 16 日（星期五）。这代表着每年 0.28 美元的股息和 0.3% 的股息收益率。Revvity 的股息支付比率（DPR）为 14.07%。</p>
<p>Revvity 宣布其董事会已于 10 月 27 日批准了一项股票回购计划，允许公司回购 10 亿美元的股票。该回购授权允许公司通过公开市场购买最多 8.7% 的股票。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
<h2>Revvity 公司简介</h2>
<p>（免费报告）</p>
<p>Revvity, Inc.在美洲、欧洲和亚洲及国际上提供健康科学解决方案、技术和服务。生命科学部门提供仪器、试剂、信息学、软件、订阅、检测、成像技术、保修、培训和服务。其诊断部门提供仪器、试剂、检测平台和软件产品，用于早期检测遗传疾病，如妊娠和早期儿童疾病，以及在诊断市场中的传染病检测。</p>
<h2>特色文章</h2>
<ul>
<li>我们更看好的五只股票比 Revvity 更好</li>
<li>成长股：它们是什么，例子以及如何投资</li>
<li>消费者得到了煤炭，但圣诞老人给这两家零售商带来了巨大的收益</li>
<li>稀释每股收益（Diluted EPS）是什么？</li>
<li>10 倍收益？这三只机器人股票可能在 2035 年前爆发</li>
<li>股票市场指数是什么，如何使用它们？</li>
<li>安海斯布希收购 BeatBox 以吸引年轻饮酒者</li>
</ul>
<p><strong>想看看其他对 RVTY 感兴趣的对冲基金持有哪些股票吗？</strong> 访问 HoldingsChannel.com 获取 Revvity Inc.（NYSE:RVTY - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 $1,000 在 Revvity 吗？</h2>
<p>在考虑 Revvity 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Revvity 并不在名单上。</p>
<p>虽然 Revvity 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

RVTY

<p>Federated Hermes Inc. 在第二季度减少了对 Revvity Inc. 的持股，降幅为 9.5%，目前持有 213,182 股，市值为 2060 万美元。其他投资者也调整了持仓，机构持有 Revvity 的比例为 86.65%。分析师的评级意见不一，普遍维持 “持有” 评级，平均目标价为 113.08 美元。Revvity 的股票开盘价为 98.85 美元，市值为 112.1 亿美元。公司报告第三季度每股收益为 1.18 美元，超出预期。宣布每股季度分红为 0.07 美元</p>

<p>Federated Hermes Inc. lowered its stake in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 9.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 213,182 shares of the company's stock after selling 22,482 shares during the period. Federated Hermes Inc. owned about 0.18% of Revvity worth $20,619,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>根据公司在最近向证券交易委员会的披露，Federated Hermes Inc. 在第二季度将其在 Revvity Inc.（纽约证券交易所代码：RVTY - 免费报告）中的股份减少了 9.5%。该机构投资者在此期间出售了 22,482 股后，持有 213,182 股该公司的股票。截至其最近向证券交易委员会的备案，Federated Hermes Inc. 持有 Revvity 约 0.18% 的股份，价值 20,619,000 美元。</p>
</div><p>Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd increased its holdings in Revvity by 25.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company's stock valued at $73,000 after buying an additional 140 shares in the last quarter. Banque Transatlantique SA grew its holdings in shares of Revvity by 19.4% in the 1st quarter. Banque Transatlantique SA now owns 925 shares of the company's stock worth $90,000 after acquiring an additional 150 shares during the period. CVA Family Office LLC increased its stake in Revvity by 79.0% in the 2nd quarter. CVA Family Office LLC now owns 410 shares of the company's stock valued at $40,000 after purchasing an additional 181 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in Revvity by 25.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 900 shares of the company's stock valued at $87,000 after purchasing an additional 185 shares in the last quarter. Finally, Leslie Global Wealth LLC raised its holdings in Revvity by 9.3% during the second quarter. Leslie Global Wealth LLC now owns 2,195 shares of the company's stock worth $212,000 after purchasing an additional 186 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他机构投资者和对冲基金最近也增加或减少了对该公司的持股。凯通国际资产管理有限公司在第一季度将其在 Revvity 的持股增加了 25.3%。凯通国际资产管理有限公司目前持有 694 股该公司的股票，价值 73,000 美元，此前在上个季度又购买了 140 股。跨大西洋银行在第一季度将其在 Revvity 的持股增加了 19.4%。跨大西洋银行目前持有 925 股该公司的股票，价值 90,000 美元，此前在此期间又收购了 150 股。CVA Family Office LLC 在第二季度将其在 Revvity 的持股增加了 79.0%。CVA Family Office LLC 目前持有 410 股该公司的股票，价值 40,000 美元，此前在上个季度又购买了 181 股。EverSource Wealth Advisors LLC 在第二季度将其在 Revvity 的持股增加了 25.9%。EverSource Wealth Advisors LLC 目前持有 900 股该公司的股票，价值 87,000 美元，此前在上个季度又购买了 185 股。最后，Leslie Global Wealth LLC 在第二季度将其在 Revvity 的持股增加了 9.3%。Leslie Global Wealth LLC 目前持有 2,195 股该公司的股票，价值 212,000 美元，此前在上个季度又购买了 186 股。目前 86.65% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级调整</h2>
</div><p>Several research firms have weighed in on RVTY. Barclays upped their target price on Revvity from $100.00 to $105.00 and gave the company an &#34;overweight&#34; rating in a report on Tuesday, October 28th. Weiss Ratings reissued a &#34;sell (d)&#34; rating on shares of Revvity in a research note on Monday. Bank of America cut their target price on shares of Revvity from $110.00 to $99.00 and set a &#34;buy&#34; rating for the company in a research report on Monday, September 22nd. Robert W. Baird increased their price target on shares of Revvity from $122.00 to $123.00 and gave the company an &#34;outperform&#34; rating in a research report on Tuesday, October 28th. Finally, Evercore ISI reissued an &#34;outperform&#34; rating and set a $108.00 price objective on shares of Revvity in a research note on Monday, October 27th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of &#34;Hold&#34; and an average price target of $113.08.</p>
<div class="lb-trans"><p>几家研究公司对 RVTY 发表了看法。巴克莱将 Revvity 的目标价格从 100.00 美元上调至 105.00 美元，并在 10 月 28 日的报告中给予该公司 “超配” 评级。Weiss Ratings 在周一的研究报告中重新发布了对 Revvity 股票的 “卖出（d）” 评级。美国银行在 9 月 22 日的研究报告中将 Revvity 的目标价格从 110.00 美元下调至 99.00 美元，并为该公司设定了 “买入” 评级。罗伯特·W·贝尔德在 10 月 28 日的研究报告中将 Revvity 的目标价格从 122.00 美元上调至 123.00 美元，并给予该公司 “跑赢大盘” 评级。最后，Evercore ISI 在 10 月 27 日的研究报告中重新发布了 “跑赢大盘” 评级，并为 Revvity 设定了 108.00 美元的目标价格。七位股票研究分析师对该股票给予了买入评级，六位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “持有”，平均目标价格为 113.08 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on RVTY</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 RVTY 股票分析</strong></p>
</div><h2>Revvity Price Performance</h2>
<div class="lb-trans"><h2>Revvity 价格表现</h2>
</div><p>Revvity stock opened at $98.85 on Wednesday. The stock has a market capitalization of $11.21 billion, a P/E ratio of 49.67, a P/E/G ratio of 3.30 and a beta of 1.06. Revvity Inc. has a 12-month low of $81.36 and a 12-month high of $128.29. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.75 and a quick ratio of 1.44. The firm's 50-day moving average is $95.54 and its two-hundred day moving average is $93.12.</p>
<div class="lb-trans"><p>Revvity 股票在周三开盘价为 98.85 美元。该公司的市值为 112.1 亿美元，市盈率为 49.67，市盈增长比率为 3.30，贝塔值为 1.06。Revvity Inc.的 12 个月最低价为 81.36 美元，最高价为 128.29 美元。该公司的债务与股本比率为 0.36，流动比率为 1.75，速动比率为 1.44。该公司的 50 日移动平均线为 95.54 美元，200 日移动平均线为 93.12 美元。</p>
</div><p>Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Monday, October 27th. The company reported $1.18 earnings per share for the quarter, beating analysts' consensus estimates of $1.14 by $0.04. Revvity had a net margin of 8.44% and a return on equity of 7.52%. The business had revenue of $698.95 million during the quarter, compared to analyst estimates of $699.75 million. During the same quarter in the previous year, the business posted $1.28 earnings per share. The company's revenue was up 2.2% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS. Equities analysts predict that Revvity Inc. will post 4.94 earnings per share for the current year.</p>
<div class="lb-trans"><p>Revvity（纽约证券交易所代码：RVTY - 获取免费报告）最近在 10 月 27 日发布了季度财报。该公司报告本季度每股收益为 1.18 美元，超出分析师共识预期的 1.14 美元，超出幅度为 0.04 美元。Revvity 的净利润率为 8.44%，股本回报率为 7.52%。该公司在本季度的收入为 6.9895 亿美元，而分析师预期为 6.9975 亿美元。在去年同期，该公司每股收益为 1.28 美元。该公司的收入同比增长了 2.2%。Revvity 已将其 2025 财年的指导目标设定为 4.900-5.000 每股收益。股票分析师预测 Revvity Inc.在当前年度将发布 4.94 美元的每股收益。</p>
</div><h2>Revvity Dividend Announcement</h2>
<div class="lb-trans"><h2>Revvity 股息公告</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 6th. Stockholders of record on Friday, January 16th will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, January 16th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity's dividend payout ratio (DPR) is 14.07%.</p>
<div class="lb-trans"><p>该公司最近还披露了一项季度股息，将于 2 月 6 日（星期五）支付。1 月 16 日（星期五）登记的股东将获得每股 0.07 美元的股息。除息日期为 1 月 16 日（星期五）。这代表着每年 0.28 美元的股息和 0.3% 的股息收益率。Revvity 的股息支付比率（DPR）为 14.07%。</p>
</div><p>Revvity declared that its board has approved a stock buyback plan on Monday, October 27th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to purchase up to 8.7% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's management believes its stock is undervalued.</p>
<div class="lb-trans"><p>Revvity 宣布其董事会已于 10 月 27 日批准了一项股票回购计划，允许公司回购 10 亿美元的股票。该回购授权允许公司通过公开市场购买最多 8.7% 的股票。股票回购计划通常表明公司的管理层认为其股票被低估。</p>
</div><h2>Revvity Company Profile</h2>
<div class="lb-trans"><h2>Revvity 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.</p>
<div class="lb-trans"><p>Revvity, Inc.在美洲、欧洲和亚洲及国际上提供健康科学解决方案、技术和服务。生命科学部门提供仪器、试剂、信息学、软件、订阅、检测、成像技术、保修、培训和服务。其诊断部门提供仪器、试剂、检测平台和软件产品，用于早期检测遗传疾病，如妊娠和早期儿童疾病，以及在诊断市场中的传染病检测。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Revvity</li>
<li>Growth Stocks: What They Are, Examples and How to Invest</li>
<li>Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers</li>
<li>What is diluted earnings per share (Diluted EPS)?</li>
<li>10X Gains? These 3 Robotics Stocks Could Explode by 2035</li>
<li>What is a Stock Market Index and How Do You Use Them?</li>
<li>Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Revvity 更好</li>
<li>成长股：它们是什么，例子以及如何投资</li>
<li>消费者得到了煤炭，但圣诞老人给这两家零售商带来了巨大的收益</li>
<li>稀释每股收益（Diluted EPS）是什么？</li>
<li>10 倍收益？这三只机器人股票可能在 2035 年前爆发</li>
<li>股票市场指数是什么，如何使用它们？</li>
<li>安海斯布希收购 BeatBox 以吸引年轻饮酒者</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding RVTY?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 RVTY 感兴趣的对冲基金持有哪些股票吗？</strong> 访问 HoldingsChannel.com 获取 Revvity Inc.（NYSE:RVTY - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=RVTY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Revvity Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Revvity 吗？</h2>
</div><p>Before you consider Revvity, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Revvity 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前... 而 Revvity 并不在名单上。</p>
</div><p>While Revvity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Revvity 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Federated Hermes Inc. 减持了其在 Revvity Inc. $RVTY 的持仓